Mumbai, March 6 -- Suven Life Sciences has allotted 3,17,68,764 equity shares of Re 1 each on conversion of warrants. Post allotment, the paid up equity share capital has increased to 2637,20,583 equity shares of Re 1 each.

Published by HT Digital Content Services with permission from Capital Market....